The big challenges of the future of global pig production are food safety, antibiotic use, animal welfare and the environmental impact, all aspects defined in sustainable production. The industry has very high production standards however consumers often don't value this.
Boehringer Ingelheim Animal Health funds three research projects for improved control of swine disease PRRS with a total of 75,000 euros
Instructions how to submit research proposals are available on www.prrs.com
Ingelheim/Germany, 09 February, 2017 – For the tenth time, Boehringer Ingelheim Animal Health has funded independent European research projects related to Porcine Circovirus Type 2 (PCV2) infection and associated diseases. Over the past ten years, 29 research projects have been awarded with € 25,000.
Ingelheim, Germany, 13 December 2016 – Having reached the milestone of 1 billion doses sold since launch, yet another vaccine of Boehringer Ingelheim Animal Health crosses a significant threshold making it one of the leading vaccines for the control of Mycoplasma hyopneumoniae globally(1).
Get the latest news on Swine Health Subscribe to our newsletter